Regulation of Developing B Cell Survival by RelA-Containing NF-κB Complexes 1
暂无分享,去创建一个
Amer A. Beg | Ye Zheng | A. Beg | Ye Zheng | Maria Prendes | M. Prendes
[1] L. Old,et al. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[2] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[3] K. Rajewsky,et al. Early B‐Cell Development in the Mouse: Insights from Mutations Introduced by Gene Targeting , 1994, Immunological reviews.
[4] Ye Zheng,et al. NF-κB RelA (p65) Is Essential for TNF-α-Induced Fas Expression but Dispensable for Both TCR-Induced Expression and Activation-Induced Cell Death1 , 2001, The Journal of Immunology.
[5] D. Baltimore,et al. Targeted Mutation of TNF Receptor I Rescues the RelA-Deficient Mouse and Reveals a Critical Role for NF-κB in Leukocyte Recruitment1 , 2001, The Journal of Immunology.
[6] F. Finkelman,et al. bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice , 1996, The Journal of experimental medicine.
[7] Z. Wang,et al. Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. , 1996, Journal of immunology.
[8] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[9] M J May,et al. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.
[10] M. Karin,et al. IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .
[11] T. Kadowaki,et al. Phosphatidylinositol 3-Kinase and NF-κB/Rel Are at the Divergence of CD40-Mediated Proliferation and Survival Pathways , 2000, The Journal of Immunology.
[12] Y. Obata,et al. NF-κB RelA-deficient Lymphocytes: Normal Development of T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.
[13] Bruce H. Horwitz,et al. Nuclear Factor κb Is Required for the Development of Marginal Zone B Lymphocytes , 2000, The Journal of experimental medicine.
[14] A. Strasser,et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.
[15] David Baltimore,et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.
[16] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[17] W. Tam,et al. Cell-Specific Association and Shuttling of IκBα Provides a Mechanism for Nuclear NF-κB in B Lymphocytes , 2001, Molecular and Cellular Biology.
[18] Susumu Tonegawa,et al. RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.
[19] Michael Karin,et al. The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling , 2000 .
[20] A. Abbas,et al. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. , 1998, Science.
[21] D. Baltimore,et al. The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3. , 1999, Journal of immunology.
[22] D. Goeddel,et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. , 2000, Immunity.
[23] T. Behrens,et al. c-Rel Is Required for the Protection of B Cells from Antigen Receptor-Mediated, But Not Fas-Mediated, Apoptosis1 , 2001, The Journal of Immunology.
[24] A. Baldwin,et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.
[25] David Baltimore,et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.
[26] M. Vig,et al. Combined Deficiency of p50 and cRel in CD4+ T Cells Reveals an Essential Requirement for Nuclear Factor κB in Regulating Mature T Cell Survival and In Vivo Function , 2003, The Journal of experimental medicine.
[27] C. Gélinas,et al. The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-xL , 2000, Molecular and Cellular Biology.
[28] D. Chao,et al. BCL-2 family: regulators of cell death. , 1998, Annual review of immunology.
[29] D. Baltimore,et al. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. , 1994, Molecular and cellular biology.
[30] R. Siegel,et al. Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.
[31] G P Nolan,et al. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. , 1993, Genes & development.
[32] D. Baltimore,et al. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. , 2009, Immunity.
[33] G. Nolan,et al. Production of high-titer helper-free retroviruses by transient transfection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[34] Steve Gerondakis,et al. The anti‐apoptotic activities of Rel and RelA required during B‐cell maturation involve the regulation of Bcl‐2 expression , 2000, The EMBO journal.
[35] D. Baltimore,et al. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. , 1997, Immunity.
[36] R. Hardy,et al. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. , 1996, Immunity.
[37] J. Tschopp,et al. NF-κB Signals Induce the Expression of c-FLIP , 2001, Molecular and Cellular Biology.
[38] W C Greene,et al. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.
[39] A. Strasser,et al. B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.